Table 3 Baseline Demographics and Clinical Characteristics, by Bleeding-related Complication and/or Blood Product Transfusion Status
Characteristic | Complication* | No Complication | P-value |
|---|---|---|---|
Number of patients | 351,065 | 1,175,208 | |
Age, mean years (SD) | 64.0 (17.9) | 55.1 (18.7) | < 0.001 |
Range | 1-89 | 1-89 | |
Male, N (%) | 159,893 (45.5%) | 432,211 (36.8%) | < 0.001 |
Race, N (%) | |||
White | 231,146 (65.8%) | 770,920 (65.6%) | < 0.001 |
Black | 46,288 (13.2%) | 143,269 (12.2%) | |
Hispanic | 12,842 (3.7%) | 58,358 (5.0%) | |
Other | 60,789 (17.3%) | 202,661 (17.2%) | |
Geographic Region, N (%) | |||
Northeast | 57,899 (16.5%) | 163,160 (13.9%) | < 0.001 |
South | 170,133 (48.5%) | 537,047 (45.7%) | |
Midwest | 60,598 (17.3%) | 259,391 (22.1%) | |
West | 58,970 (16.8%) | 204,439 (17.4%) | |
Unknown | 3,465 (1.0%) | 11,171 (1.0%) | |
Primary Payer, N (%) | |||
Medicare | 202,495 (57.7%) | 443,685 (37.8%) | < 0.001 |
Medicaid | 24,477 (7.0%) | 110,654 (9.4%) | |
Private | 98,132 (28.0%) | 524,710 (44.6%) | |
Uninsured | 13,495 (3.8%) | 45,219 (3.8%) | |
Other | 12,466 (3.6%) | 50,940 (4.3%) | |
Comorbidity, N (%) | |||
Diabetes | 162,097 (46.2%) | 306,512 (26.1%) | < 0.001 |
Obesity | 41,646 (11.9%) | 150,510 (12.8%) | < 0.001 |
COPD | 88,506 (25.2%) | 219,635 (18.7%) | < 0.001 |
Cancer | 80,506 (22.9%) | 198,206 (16.9%) | < 0.001 |
Cirrhosis | 11,034 (3.1%) | 9,835 (0.8%) | < 0.001 |
Prior Hospitalization, N (%) | 161,956 (46.1%) | 486,348 (41.4%) | < 0.001 |
Prior Surgery, N (%) | 106,064 (30.2%) | 293,533 (25.0%) | < 0.001 |
Pre-operative use of substances that promote hemostasis, N (%) | 7,957 (2.3%) | 21,338 (1.8%) | < 0.001 |